Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis.
Petkau
J
J
Department of Statistics, University of British Columbia, Vancouver, Canada.
White
R
R
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000906:Antibodies / Q000032:analysis / Q000276:immunology*; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000276:immunology* / Q000503:physiopathology / Q000628:therapy*; D009500:Neutralization Tests; D012008:Recurrence
D000276:Adjuvants, Immunologic; D000906:Antibodies; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a